Baker Brothers Advisors - SUNESIS PHARMACEUTICALS INC ownership

SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328700. A total of 5 filers reported holding SUNESIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of SUNESIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$66,000
-55.1%
53,066
-90.5%
0.00%
-100.0%
Q2 2020$147,000
-36.4%
556,6650.0%0.00%0.0%
Q1 2020$231,000
+22.9%
556,6650.0%0.00%0.0%
Q4 2019$188,000
-53.1%
556,6650.0%0.00%
-66.7%
Q3 2019$401,000
-1.0%
556,6650.0%0.00%0.0%
Q2 2019$405,000
-40.1%
556,6650.0%0.00%
-25.0%
Q1 2019$676,000
+192.6%
556,6650.0%0.00%
+100.0%
Q4 2018$231,000
-79.2%
556,6650.0%0.00%
-71.4%
Q3 2018$1,113,000
-5.7%
556,6650.0%0.01%
-22.2%
Q2 2018$1,180,000
-22.1%
556,6650.0%0.01%
-30.8%
Q1 2018$1,514,000
-44.7%
556,665
-24.9%
0.01%
-45.8%
Q4 2017$2,737,000
+90.2%
741,6650.0%0.02%
+100.0%
Q3 2017$1,439,000
-28.1%
741,6650.0%0.01%
-33.3%
Q2 2017$2,002,000
-34.2%
741,6650.0%0.02%
-28.0%
Q1 2017$3,041,000
+13.3%
741,6650.0%0.02%
-3.8%
Q4 2016$2,685,000
-17.2%
741,6650.0%0.03%
-10.3%
Q3 2016$3,241,000741,6650.03%
Other shareholders
SUNESIS PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Aisling Capital Management LP 7,600,000$9,234,0007.03%
Samsara BioCapital, LLC 3,750,000$4,556,0003.58%
CAXTON CORP 277,245$337,0000.31%
BVF INC/IL 2,287,860$2,780,0000.31%
Eventide Asset Management 5,965,455$7,248,0000.25%
Telemetry Investments, L.L.C. 197,564$240,0000.12%
NEA Management Company, LLC 1,298,274$1,584,0000.08%
RP Management, LLC 129,517$158,0000.08%
Palo Alto Investors LP 1,162,473$1,412,0000.06%
Fosun International Ltd 725,000$863,0000.06%
View complete list of SUNESIS PHARMACEUTICALS INC shareholders